DR. CHARLES WILLIAM MURPHY M.D. NPI 1639178908

NPI Details

DR. Charles William Murphy, M.D. is an interventional pain medicine pain medicine in San Antonio, TX with 46 years of experience. The provider is interventional Pain Medicine is the discipline of medicine devoted to the diagnosis and treatment of pain and related disorders principally with the application of interventional techniques in managing subacute, chronic, persistent, and intractable pain, independently or in conjunction with other modalities of treatment. DR. Charles William Murphy, M.D. NPI is 1639178908. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL SCHOOL AT DALLAS
Graduation Year:1980

The provider's business location address is:

14800 SAN PEDRO AVE STE 202
SAN ANTONIO, TX
ZIP 78232-734
Phone: (210) 253-3313

The NPI 1639178908 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Injection, methylprednisolone acetate, 40 mg (HCPCS:J1030)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, single level (HCPCS:64483)
• Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level (HCPCS:64484)
• Injection, methylprednisolone acetate, 20 mg (HCPCS:J1020)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Testing for presence of drug, read by direct observation (HCPCS:80305)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• Injection of substance into middle or upper spine canal using imaging guidance (HCPCS:62321)
• Injection of substance into lower spine canal using imaging guidance (HCPCS:62323)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64636)
• Injection of lower or sacral spine facet joint using imaging guidance, single level (HCPCS:64493)
• Compounded drug, not otherwise classified (HCPCS:J7999)
• Injection of lower or sacral spine facet joint using imaging guidance, second level (HCPCS:64494)
• Injection of upper or middle spine facet joint using imaging guidance, single level (HCPCS:64490)
• Established patient office or other outpatient visit, 10-19 minutes (HCPCS:99212)
• Injection of upper or middle spine facet joint using imaging guidance, second level (HCPCS:64491)
• Injection, methylprednisolone acetate, 80 mg (HCPCS:J1040)
• Injection of trigger points, 1-2 muscles (HCPCS:20552)
• Fluoroscopic guidance for needle placement (HCPCS:77002)
• Injection of anesthetic or steroid into joint between lower spine and hip bone using imaging guidance (HCPCS:27096)
• Destruction of lower or sacral spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64635)
• Electronic analysis reprogramming and refill of spinal canal drug infusion pump (HCPCS:62369)
• Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
• Ultrasonic guidance for needle placement (HCPCS:76942)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint (HCPCS:64634)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0480)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Destruction of upper or middle spinal facet joint nerves using imaging guidance, single facet joint (HCPCS:64633)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Injection of trigger points, 3 or more muscles (HCPCS:20553)
• Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (HCPCS:G0481)

The enumeration date for this NPI number is 7/19/2005 and was last updated on 7/30/2025.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: